Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
semaglutide
Pharma
Novo inks Wegovy deals with telehealth companies
Novo Nordisk appears to be letting compounded GLP-1 bygones be bygones—at least, in one respect.
Andrea Park
Apr 29, 2025 11:05am
Compounders ordered to halt production of semaglutide knockoffs
Apr 25, 2025 10:25am
BMO says Lilly is pulling ahead of Novo in obesity market battle
Apr 17, 2025 4:30pm
Novo charts $1B-plus Brazilian production expansion for GLP-1s
Apr 8, 2025 9:40am
Novo's oral GLP-1 Rybelsus cuts heart disease risks
Mar 31, 2025 11:30am
Texas judge allows Novo Nordisk to intervene in compounders suit
Mar 6, 2025 8:45am
